Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Shares Outstanding (Weighted Average): 2013-2024

Historic Shares Outstanding (Weighted Average) for Neurogene (NGNE) over the last 12 years, with Dec 2024 value amounting to $14.9 million.

  • Neurogene's Shares Outstanding (Weighted Average) rose 9.84% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 9.84%. This contributed to the annual value of $14.9 million for FY2024, which is 532.26% up from last year.
  • Latest data reveals that Neurogene reported Shares Outstanding (Weighted Average) of $14.9 million as of FY2024, which was up 532.26% from $2.3 million recorded in FY2023.
  • In the past 5 years, Neurogene's Shares Outstanding (Weighted Average) registered a high of $14.9 million during FY2024, and its lowest value of $2.1 million during FY2020.
  • In the last 3 years, Neurogene's Shares Outstanding (Weighted Average) had a median value of $2.3 million in 2023 and averaged $6.4 million.
  • Data for Neurogene's Shares Outstanding (Weighted Average) shows a peak YoY soared of 532.26% (in 2024) over the last 5 years.
  • Neurogene's Shares Outstanding (Weighted Average) (Yearly) stood at $2.1 million in 2020, then climbed by 1.27% to $2.1 million in 2021, then increased by 0.39% to $2.1 million in 2022, then increased by 10.32% to $2.3 million in 2023, then spiked by 532.26% to $14.9 million in 2024.